Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

20937 Press Releases
DateTitleCompany
20 Jun 18 Orion Corporation: Managers' transactions - Anne Karvonen Orion Oyj,
Published by
GlobeNewswire
20 Jun 18 EPIC's Philip Westphal to Present on Safe Patient Handling at the California Rural Health Conference EPIC Insurance Brokers and Consultants,
Published by
PR Newswire
20 Jun 18 Complia Health Appoints Rick Genovese as Executive Chairman Complia Health,
Published by
PR Newswire
20 Jun 18 Troubling New Report on Hospital Infections Comes While the Centers for Medicare & Medicaid Services Considers Discontinuing Publicly Reporting Rates Castlight Health,
Published by
PR Newswire
20 Jun 18 Ambulatory Surgical Centers Market Will Retain 5% CAGR to Cross $93 Billion by 2024: Global Market Insights, Inc. Global Market Insights, Inc.,
Published by
PR Newswire
20 Jun 18 DDi’s Patent-pending LABELai has New Version for Cloud to Address Labeling Challenges Effectively DDi
20 Jun 18 ObsEva Announces Pricing of Follow-on Public Offering Published by
GlobeNewswire
20 Jun 18 Publication of offer document by Nordic Transport Group Holding A/S Published by
GlobeNewswire
20 Jun 18 ObsEva Announces Pricing of Follow-on Public Offering ObsEva SA,
Published by
GlobeNewswire
20 Jun 18 Full Brochure Available for Nicholas Hall's OTC.NewDirections Executive Conference - Where Innovation Meets Regulation The Nicholas Hall Group,
Published by
PR Newswire
20 Jun 18 Ethypharm Appoints Frédéric MOLIN to Leads Its Corporate Development Ethypharm,
Published by
PR Newswire
20 Jun 18 ERYTECH to Present at JMP Securities Life Science Conference Published by
GlobeNewswire
20 Jun 18 Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management Published by
GlobeNewswire
20 Jun 18 argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris Published by
GlobeNewswire
20 Jun 18 iTeos Therapeutics Completes $75 Million Series B Financing Published by
GlobeNewswire
20 Jun 18 ERYTECH to Present at JMP Securities Life Science Conference Erytech Pharma S.A.,
Published by
GlobeNewswire
20 Jun 18 Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management Idorsia Pharmaceuticals Ltd.,
Published by
GlobeNewswire
20 Jun 18 argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris argenx SE,
Published by
GlobeNewswire
20 Jun 18 Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada Published by
GlobeNewswire
20 Jun 18 The Ensign Group Acquires Office Building in Orange County, California Published by
GlobeNewswire
20 Jun 18 MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia and Hypercholesterolemia in Japan Published by
GlobeNewswire
20 Jun 18 Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement Published by
GlobeNewswire
20 Jun 18 WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center WuXi Biologics,
Published by
PR Newswire
19 Jun 18 Vigil Health Solutions Reports Record Sales Bookings for Fiscal 2018 Published by
GlobeNewswire
19 Jun 18 RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso Published by
GlobeNewswire
19 Jun 18 CORRECTING and REPLACING -- Pascal Biosciences Engages CFN Media to Build New Investor Audience -- CFN Media Published by
GlobeNewswire
19 Jun 18 Optimum Nutrition Inspires On-The-Go Consumers to Snack Better Optimum Nutrition,
Published by
PR Newswire
19 Jun 18 Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018 Published by
GlobeNewswire
19 Jun 18 Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering Published by
GlobeNewswire
19 Jun 18 Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology Published by
GlobeNewswire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.